The major successes of anti-VEGF-A/VEGFR therapies in mice have been in the prevention of the growth of freshly transplanted mouse tumors and tumor xenografts [23, 26] (for additional references, see [27, 28]). The gene discussed is VEGFA; the disease is neoplasm.